文献速递血栓与止血

静脉注射免疫球蛋白治疗增加儿童免疫性血小板减少症患者血小板凝血酶激活与凝血酶生成

IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia.
PubMed 文献 · Br J Haematol · 2023-03-02

研究纳入23例新诊断免疫性血小板减少症(ITP)患儿,在静脉注射免疫球蛋白(IVIg)治疗前后检测止血相关临床表现与实验室指标,并与健康儿童及化疗相关血小板减少儿童比较。ITP患儿诊断时血小板CD62P、CD63及活化caspase表达增加、凝血酶生成减少,凝血酶诱导的血小板活化降低;IVIg治疗后网织血小板增多、血小板计数升至20×10^9/L以上、出血改善,凝血酶诱导的血小板活化及凝血酶生成均改善。

要点

  • 新诊断ITP患儿存在血小板活化与凋亡标志物增加及凝血酶生成减少。
  • ITP患儿凝血酶诱导的血小板活化较对照组降低。
  • IVIg治疗改善患儿出血、提升血小板计数并改善血小板功能与凝血。

核心结论

  • 结果提示IVIg治疗有助于改善新诊断ITP患儿的血小板功能减低与凝血异常。

研究设计与样本

  • 研究纳入23例新诊断免疫性血小板减少症(ITP)患儿,在IVIg治疗前后检测止血相关临床表现与实验室指标。

主要发现

  • ITP患儿诊断时表达CD62P、CD63及活化caspase的血小板比例增加,凝血酶生成减少。

关键数值与推荐

  • ITP患儿血小板计数低于20×10^9/L且出血症状轻微,出血按标准化出血评分(BS)分级。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Clinical manifestations and laboratory parameters of haemostasis were investigated in 23 children with newly diagnosed immune thrombocytopenia (ITP) before and after intravenous immunoglobulin (IVIg) treatment. ITP patients with platelet counts of less than 20 × 109 /L and mild bleeding symptoms, graded by a standardized bleeding score (BS), were compared with healthy children with normal platelet counts and children with chemotherapy-related thrombocytopenia. Markers of platelet activation and platelet apoptosis in the absence and presence of platelet activators were analysed by flow cytometry; thrombin generation in plasma was determined. ITP patients at diagnosis presented with increased proportions of platelets expressing CD62P and CD63 and activated caspases, and with decreased thrombin generation. Thrombin-induced activation of platelets was reduced in ITP compared with controls, while increased proportions of platelets with activated caspases were observed. Children with a higher BS had lower proportions of CD62P-expressing platelets compared with those with a lower BS. IVIg treatment increased the number of reticulated platelets, the platelet count to more than 20 × 109 /L and improved bleeding in all patients. Decreased thrombin-induced platelet activation, as well as thrombin generation, were ameliorated. Our results indicate that IVIg treatment helps to counteract diminished platelet function and coagulation in children with newly diagnosed ITP.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Schmugge M, Franzoso FD, Winkler J, et al. IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia. Br J Haematol. 2023. PMID: 36861460. doi:10.1111/bjh.18702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。